Becton, Dickinson & Co. (BDX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Becton, Dickinson & Co. (BDX)
Go deeper and ask any question about BDX
Company Performance
Current Price
as of Sep 13, 2024$234.18
P/E Ratio
48.18
Market Cap
$67.69B
Description
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Metrics
Overview
- HQFranklin Lakes, NJ
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBDX
- Price$234.18-0.56%
Trading Information
- Market Cap$67.69B
- Float99.86%
- Average Daily Volume (1m)1,231,960
- Average Daily Volume (3m)1,376,965
- EPS$4.88
Company
- Revenue$19.83B
- Rev Growth (1yr)2.30%
- Net Income$487.00M
- Gross Margin46.23%
- EBITDA Margin25.71%
- EBITDA$1.28B
- EV$81.82B
- EV/Revenue4.13
- P/E48.18
- P/S3.43